{"Symbol": "ILMN", "AssetType": "Common Stock", "Name": "Illumina Inc", "Description": "Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.", "CIK": "1110803", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DIAGNOSTICS & RESEARCH", "Address": "5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122", "OfficialSite": "https://www.illumina.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "17860250000", "EBITDA": "1139000000", "PERatio": "21.39", "PEGRatio": "0.622", "BookValue": "17.8", "DividendPerShare": "None", "DividendYield": "None", "EPS": "5.46", "RevenuePerShareTTM": "28.02", "ProfitMargin": "0.196", "OperatingMarginTTM": "0.197", "ReturnOnAssetsTTM": "0.0839", "ReturnOnEquityTTM": "0.334", "RevenueTTM": "4343000000", "GrossProfitTTM": "2964000000", "DilutedEPSTTM": "5.46", "QuarterlyEarningsGrowthYOY": "0.864", "QuarterlyRevenueGrowthYOY": "0.05", "AnalystTargetPrice": "135.84", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "7", "AnalystRatingHold": "8", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "2", "TrailingPE": "21.39", "ForwardPE": "22.62", "PriceToSalesRatioTTM": "4.112", "PriceToBookRatio": "6.56", "EVToRevenue": "4.324", "EVToEBITDA": "12.89", "Beta": "1.449", "52WeekHigh": "155.53", "52WeekLow": "68.7", "50DayMovingAverage": "136.78", "200DayMovingAverage": "107.87", "SharesOutstanding": "152900000", "SharesFloat": "148646000", "PercentInsiders": "0.194", "PercentInstitutions": "105.913", "DividendDate": "None", "ExDividendDate": "None"}